Association between mean platelet volume and severity of rheumatoid arthritis

Jamileh Moghimi1,2, Farahnaz Ghahremanfard2, Maryam Salari2

  • 1Social Determinants of Health Research Center, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.

Abstract

Insights

Mean platelet volume (MPV) did not correlate with rheumatoid arthritis (RA) disease activity in a 4-month study. Treatment reduced RA activity but did not impact MPV levels, suggesting MPV is not a reliable predictor of RA disease activity.

Area of Science:

  • Rheumatology
  • Hematology
  • Clinical Diagnostics

Background:

  • Rheumatoid arthritis (RA) activity is a key factor in disease management.
  • Platelet histogram indices, including mean platelet volume (MPV), have been investigated for potential associations with RA.
  • Understanding reliable biomarkers for RA activity is crucial for effective patient care.

Purpose of the Study:

  • To assess the relationship between mean platelet volume (MPV) and rheumatoid arthritis (RA) disease activity.
  • To determine if MPV can serve as a predictive marker for RA activity during treatment.

Main Methods:

  • Sixty RA patients meeting ACR criteria were enrolled.
  • Disease activity was assessed using the DAS-28 score at baseline, 2, and 4 months.
  • Complete blood counts (including MPV), CRP, and ESR were measured at each visit.

Main Results:

  • A significant reduction in DAS-28 scores was observed over 4 months (p < 0.001).
  • No significant changes or correlations were found between MPV levels and DAS-28 scores throughout the study.
  • While CRP levels decreased, MPV, platelet count, and ESR trends were not significant.

Conclusions:

  • Therapeutic regimens effectively reduced RA activity but did not influence MPV levels within the 4-month period.
  • Mean platelet volume (MPV) does not appear to be a reliable indicator for predicting disease activity in rheumatoid arthritis patients.
  • Further research may be needed to explore other potential roles or contexts for MPV in RA.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
581
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
711
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.9K